Germ-line mutations in epidermal growth factor receptor (<it>EGFR) </it>are rare but may contribute to oncogenesis: A novel germ-line mutation in <it>EGFR </it>detected in a patient with lung adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>A subset of lung cancer patients harbour <it>EGFR </it>somatic mutations in their tumours and are candidates for treatment with EGFR tyrosine kinase inhibitors. In a few cases <it>EGFR </it>mutations have also...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/172 |